Clinical Trial Update: Trastuzumab Administered Concurrently or Sequentially to Anthracycline-containing Adjuvant Regimen for Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports on Phase 2 and Phase 3 studies evaluating trastuzumab given concurrently or sequentially with anthracycline-containing adjuva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• HERCEPTIN (trastuzumab)

Snippet

Sponsor: Peking Union Medical College Hospital | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: COMPLETED